跳到正文

Celularity Inc 向 SEC 提交 8-K 当前报告,披露其他事件及财务报表与附件

SEC EDGAR 8-K·(美东 10月29日 09:24)· 3 天前

8-K - Celularity Inc (0001752828) (Filer)

AI 导读

Celularity Inc(CIK 0001752828)于 2026-10-29 向 SEC 提交 8-K 当前报告,报告期同为 2026-10-29,文件包含 Item 8.01(其他事件)和 Item 9.01(财务报表与附件),共 12 份文件,含 EX-99.1 附件及 XBRL 相关文件。

报错 · 内容有误?请告诉我们。

正文 · 原文

Form 8-K - Current report:

SEC Accession No. 0001493152-26-049203

Filing Date

2026-10-29

Accepted

2026-10-29 09:24:54

Documents

12

Period of Report

2026-10-29

Items

Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 39570
2 EX-99.1 ex99-1.htm EX-99.1 24590
  Complete submission text file 0001493152-26-049203.txt   236272

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE celu-20261029.xsd EX-101.SCH 3020
4 XBRL LABEL FILE celu-20261029_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE celu-20261029_pre.xml EX-101.PRE 22362
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3257

Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932

Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170

Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

EIN.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38914 | Film No.: 261497867
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

来源:SEC EDGAR 8-K · sec.gov